Competition Healthcare Provider White Paper 
PM360
MAY 21, 2024
During the COVID-19 pandemic, pharma organizations built new digital and virtual channels to communicate with healthcare providers (HCPs) outside of their offices. The channels alone aren’t going to produce the desired uptick in engagement without content that’s customized for each channel and personalized for each provider.
Pharma Marketing Network
DECEMBER 19, 2024
Demographics: Factors like age, gender, and socioeconomic status often determine healthcare decisions. Healthcare Providers: Key Influencers Physicians, nurses, and pharmacists are the gatekeepers of medical advice and treatment recommendations. What is audience targeting in pharma marketing?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Salesforce
OCTOBER 10, 2024
Security and regulatory implications of digital transformation in healthcare As HLS organizations move quickly to innovate, they must also safeguard data, comply with regulations, and protect their systems from cyber threats. And in healthcare, data security is more than a technical issue — it’s about maintaining trust.
Pharmaceutical Representative Training
OCTOBER 9, 2024
Introduction In today’s competitive business environment, sales professionals face the challenge of optimizing their time and resources to achieve success. In this competitive world of sales, especially in pharmaceuticals, the mantra “quality over quantity” holds true.
European Pharmaceutical Review
DECEMBER 21, 2022
16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. EFPIA White Paper on Circular Economy, June 2020. Org Process Res Dev 2020, 24, 10, 1996–2003. Recycling of medical plastics.
Pharmaceutical Technology
JANUARY 6, 2023
The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.
Pharmaceutical Technology
NOVEMBER 30, 2022
NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.
Expert insights. Personalized for you.
59 
Let's personalize your content